Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis

Journal of Hepatology

Volumn 34, Issue 4, 2001, Pages 576-583

  Patella, Shane ^a   Phillips, David J ^b   De Kretser, David M ^b   Evans, Lee W ^c   Groome, Nigel P ^c   Sievert, William ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Activin A; Follistatin; Hepatitis B: Hepatitis C; Pathogenesis

Indexed keywords

ACTIVIN A; AMINOTRANSFERASE; FOLLISTATIN; VIRUS DNA;

ADULT; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS HEPATITIS; VIRUS REPLICATION;

ACTIVINS; ADULT; APOPTOSIS; FEMALE; FOLLISTATIN; GLYCOPROTEINS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBINS; MALE; OSMOLAR CONCENTRATION;

EID: 0035058793     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)00029-5     Document Type: Article

References (36)

1. Pathogenesis of liver fibrosis
2. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat
3. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines
4. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid
5. Regulation of cellular and system function by activin
6. Activin-A: An autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes
7. Induction of apoptosis in the murine liver with recombinant human activin-A
8. Activin induces cell death in hepatocytes in vivo and in vitro
9. Localization and cellular sources of activins in normal and fibrotic rat liver
10. Expression of activin-A is increased in cirrhotic and fibrotic rat livers
11. Structural characterization of follistatin: A novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad
12. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats
13. Intravenous administration of follistatin: Delivery to the liver and effect on liver regeneration after partial hepatectomy
14. Follistatin: A multifunctional regulatory protein
15. Serum immunoreactive activin-A levels in normal subjects and patients with various diseases
16. Determination of free follistatin levels in sera of normal subjects and patients with various diseases
17. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid
18. Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin
19. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis
20. Elevated serum type IV collagen: A sensitive indicator of the presence of cirrhosis in haemochromatosis
21. Differential localization of inhibin subunit proteins in the ovine testis during fetal gonadal development
22. Expression of activin-A and follistatin core proteins by human prostate tumor cell lines
23. Histological grading and staging of chronic hepatitis
24. Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease
25. Characterization of tissue inhibitor of metalloproteinases-1 in plasma from patients with chronic liver disease
26. Alcohol consumption induces hepatocyte apoptosis in patients with chronic Hepatitis C virus infection
27. Activin-A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin
28. Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis
29. Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis
30. Urinary transforming growth factor beta1 levels in hepatitis C virus-related chronic liver disease: Correlation between high levels and severity of disease
31. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
32. Naïve and memory T cell infiltrates in chronic hepatitis C: Phenotypic changes with interferon treatment
33. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections
34. Induction of prostanoid, nitric oxide and cytokine formation in rat bone marrow derived macrophages by activin-A
35. Differential regulation of activin-A for hepatocyte growth and fibronectin synthesis in rat liver injury
36. The proto-oncogene Bcl-2 and its role in regulating apoptosis